Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

21.2%

7 terminated/withdrawn out of 33 trials

Success Rate

75.9%

-10.6% vs industry average

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

59%

13 of 22 completed trials have results

Key Signals

13 with results6 terminated

Enrollment Performance

Analytics

N/A
22(84.6%)
Phase 4
2(7.7%)
Phase 3
1(3.8%)
Phase 2
1(3.8%)
26Total
N/A(22)
Phase 4(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (33)

Showing 20 of 33 trials
NCT02871258Not ApplicableCompleted

MetaNeb® Chest X-ray Study

Role: lead

NCT00771238Not ApplicableCompleted

Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds

Role: lead

NCT04017312Not ApplicableTerminated

A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting

Role: lead

NCT03797677Not ApplicableCompleted

MN4000 for Treatment of CF and MND Patients in the Home Setting

Role: lead

NCT02627742Not ApplicableCompleted

Evaluation of The MetaNeb® System to Reduce Postoperative Pulmonary Complications

Role: lead

NCT04582214Not ApplicableUnknown

Oscillation and Lung Expansion Therapy in Patients With COVID-19

Role: lead

NCT02412046Not ApplicableTerminated

Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics

Role: collaborator

NCT03114345Not ApplicableTerminated

Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient

Role: collaborator

NCT03971721Not ApplicableTerminated

Hill-Rom WAVE for Positional Obstructive Sleep Apnea at Home

Role: collaborator

NCT04627272Not ApplicableUnknown

AutoDx-DR Prospective Clinical Validation Study Protocol

Role: lead

NCT04581161Not ApplicableUnknown

Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients

Role: lead

NCT03463434Not ApplicableCompleted

AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries

Role: lead

NCT03628833Not ApplicableCompleted

Incontinence Management System ICU Field Evaluation

Role: lead

NCT03645473Not ApplicableUnknown

Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance System

Role: lead

NCT00181207Phase 4Completed

Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

Role: collaborator

NCT02250417Not ApplicableCompleted

Investigation of a Novel Sleep Surface for Treatment of Positional Sleep Apnea

Role: collaborator

NCT00181285Not ApplicableCompleted

Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)

Role: collaborator

NCT03091062Not ApplicableCompleted

Evaluation of an Airway Clearance System

Role: lead

NCT03023072Terminated

Evaluation of an Incontinence Product

Role: lead

NCT00717873Not ApplicableCompleted

Evaluation of High-Frequency Chest Wall Oscillation

Role: lead